MACLIRYS

Serial Number 79278426
Registration 6317738
700

Registration Progress

Application Filed
Dec 18, 2019
Under Examination
Approved for Publication
Jan 26, 2021
Published for Opposition
Jan 26, 2021
Registered
Apr 13, 2021

Trademark Image

MACLIRYS

Basic Information

Serial Number
79278426
Registration Number
6317738
Filing Date
December 18, 2019
Registration Date
April 13, 2021
Published for Opposition
January 26, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 13, 2021
Registration
Registered
Classes
005 010

Rights Holder

STADA Arzneimittel AG

99
Address
Stadastr. 2-18
61118 Bad Vilbel
DE

Ownership History

STADA Arzneimittel AG

Original Applicant
99
61118 Bad Vilbel DE

STADA Arzneimittel AG

Owner at Publication
99
61118 Bad Vilbel DE

STADA Arzneimittel AG

Original Registrant
99
61118 Bad Vilbel DE

Legal Representation

Attorney
Charles T. J. Weigell

USPTO Deadlines

Next Deadline
624 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-04-13)
Due Date
April 13, 2027
Grace Period Ends
October 13, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Aug 14, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 26, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 26, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 13, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 4, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Apr 13, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 26, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 26, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 24, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jan 6, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 6, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jan 6, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 21, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 21, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 21, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 21, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 21, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 14, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 14, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 11, 2020 ALIE A ASSIGNED TO LIE Loading...
Sep 18, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 5, 2020 LIME X LIMITATION FROM THE IB - REQUEST EXAM REVIEW Loading...
Aug 5, 2020 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Jul 27, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 27, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 27, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 27, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jul 27, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 27, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 22, 2020 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Apr 10, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 20, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 20, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 4, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 3, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 2, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 18, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 14, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 13, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Applicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "MACLIRYS" has no meaning in a foreign language.

Classification

International Classes
005 010